DiabetologyNews.net

Diabetology Xagena

Search results for "Diabetes mellitus"

The FDA ( Food and Drug Administration ) approved Symlin, an injectable drug to control blood sugar for adults with type 1 and type 2 diabetes. Symlin is to be used in addition to insulin therapy in ...


A temporary rise in blood glucose levels in people with both types of diabetes can interfere with their ability to think quickly and solve problems. The study has been published in Diabetes Care. ...


Increasing physical activity can greatly increase the health of people with type 2 diabetes, by reducing the risk for heart disease and helping to prevent other diabetes-related complications. Now ...


Results of a multi-center study, which screened more than 2,000 men, found sexual dysfunction to be the most common symptom experienced by men with diabetes and low testosterone ( hypogonadism ). In ...


A study found that type 2 diabetes may be significantly delayed or prevented through medication that takes the load off of the body's delicate insulin-producing cells. The Pioglitazone in Preventio ...


Clinical trials suggest that Rosiglitazone ( Avandia ), a drug that helps control blood glucose levels, may also reduce blood pressure in people with type 2 diabetes. According to the American Hear ...


GLAD ( Glucose and Lipid Assessment in Diabetes ), a phase II dose-ranging study, assessed the effects of Tesaglitazar ( Galida ) on glucose and lipid abnormalities in patients with type 2 diabetes. ...


Rimonabant ( Acomplia ) has demonstrated that it can lower blood glucose and reduce weight and waist circumference, as well as modify lipids associated with diabetic dyslipidemia, in patients with typ ...


Results from a study indicating that Exenatide ( Byetta ) injection showed sustained improvements in blood glucose control and progressive weight reduction through a year and a half of therapy for peo ...


Researchers from the Keck School of Medicine of the University of Southern California and Childrens Hospital Los Angeles found youths with type 1 diabetes, especially boys, already show early signs of ...


Investigators at Joslin Diabetes Center first identified genes that were altered in their level of expression in islets isolated from people with type 2 diabetes. The researchers then went on to show ...


Results from three Phase II studies showed that Sitagliptin ( Januvia ), an investigational medicine in a potentially new class of agents for the treatment for diabetes called DPP-IV ( dipeptidyl pep ...


A tight glucose control in people with type 1 diabetes can reduce significantly the risk of heart disease. This finding is based on analysis of the cardiovascular ( CVD ) events such as heart att ...


Results from a new prespecified analysis of the VYVA ( VYtorin Versus Atorvastatin ) trial involving a subgroup of 428 patients with type 2 diabetes were consistent with the overall VYVA trial. In ...


The study was designed to assess the safety, tolerability and pharmacokinetics of Exenatide ( Byetta ) LAR (long-acting release ) given once a week. After 15 weeks, both doses of Exenatide LAR were ...